Recent Updates
Recently added Catalysts
MRVI Positive Sentiment

Maravai LifeSciences Announces November 2026 Investor Conference Schedule

Thursday, October 29, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Maravai LifeSciences announced its schedule for two November 2026 investor conferences. CFO Raj Asarpota will attend a fireside chat at the Stifel Healthcare Conference on November 12. The company plans to participate in an additional event on November 17. These appearances aim to engage with the investment community.

Market Sentiment Analysis

POSITIVE FACTORS

  • Maravai LifeSciences is actively engaging with investors.
  • Participation in notable conferences enhances visibility.
  • Leadership presence at events reflects company commitment.

Full Press Release Details

SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the month of November. On November 12, 2026, at 10:40 a.m. EST, Raj Asarpota, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Stifel Healthcare Conference in New York City, NY. On November 17, 2026, at 4:00 p.m.

Frequently Asked Questions

When is Maravai's investor conference participation?

Maravai will participate in conferences on November 12 and 17, 2026.

Who will represent Maravai at the conferences?

Raj Asarpota, the CFO, will represent Maravai at the events.

What is the Stifel Healthcare Conference?

It is an investor conference where Maravai will engage with investors.

Where will the conferences take place?

The conferences will be held in New York City, NY.

ShareAdd on Google
Tags: MRVI Maravai LifeSciences investor conference Raj Asarpota Stifel Healthcare Conference
Last updated: Oct 29, 2026

Biotech snapshot

Cash runway
$70M liquidity · $0M/mo burn
Low dilution risk